Suscribirse

Mesohepatectomy - 05/09/11

Doi : 10.1016/S0002-9610(00)00374-3 
Charles H Scudamore, MD, MSc a, ⁎, Andrzej K Buczkowski, MD a, Hossein Shayan, MSc a, Stephen G.F Ho, MD b, Gerald M Legiehn, MD b, Stephen W Chung, MD, PhD a, David A Owen, MB c
a Department of Surgery (CHS, AKB, HS, SWC), Vancouver Hospital and Health Sciences Center, University of British Columbia, Vancouver, British Columbia, Canada 
b Department of Radiology (SDFH, GML), Vancouver Hospital and Health Sciences Center, University of British Columbia, Vancouver, British Columbia, Canada 
c Department of Pathology and Laboratory Medicine (DAO), Vancouver Hospital and Health Sciences Center, University of British Columbia, Vancouver, British Columbia, Canada 

*Requests for reprints should be addressed to Charles H. Scudamore, MD, Head, Section of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Faculty of Medicine, Vancouver Hospital and Health Sciences Center, 910 West 10th Avenue, 3rd Floor, Vancouver, British Columbia, Canada V5Z 4E3

Abstract

Background: Formal anatomic (lobar) or extended hepatectomies are recommended for liver malignancies located centrally within the liver (Couinaud’s segments IVA, IVB, V, and VIII). Mesohepatectomy, resection of central hepatic segments and leaving the right and left segments in situ, removes large central tumors preserving more functioning liver tissue than either extended left or right hepatectomy. Mesohepatectomy is a seldom used, technically demanding procedure, and its application is yet to be defined.

Methods: Medical charts of 244 consecutive liver resection patients were reviewed retrospectively. Eighteen patients were treated with mesohepatectomy. Six patients had metastatic liver tumor (MLT), 11 had hepatocellular carcinoma (HCC), and 1 had gallbladder adenocarcinoma. The operative results were compared with groups of patients treated by lobar hepatectomy (n = 71) and extended left or right hepatectomy (n = 43).

Results: The mean mesohepatectomy operative time was 238 versus 304 minutes in the extended group. Inflow occlusion mean time was longer in the mesohepatectomy group than in extended procedures, 45 versus 39 minutes (P = not significant). Comparing the extended hepatectomy group, the mesohepatectomy group had a mean operative estimated blood loss 914 cc versus 1628 cc (P <0.01), postoperative hospital stay 9 versus 16 days (P = 0.054) and volume of resected liver 560cc versus 1500cc (P <0.01) respectively. The late complication rate was lower in the mesohepatectomy group than in the extended group and was comparable to the lobar hepatectomy group (P = 0.05).

Conclusions: Despite its technical demands, mesohepatectomy should be considered as an alternative to extended hepatectomy for selected patients with primary and secondary hepatic tumors localized in middle liver segments, as its complication rate, postoperative recovery, and preserved liver tissue compare favorably with extended hepatic resection.

El texto completo de este artículo está disponible en PDF.

Esquema


© 2000  Excerpta Medica Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 179 - N° 5

P. 356-360 - mai 2000 Regresar al número
Artículo precedente Artículo precedente
  • Computed tomography severity index is a predictor of outcomes for severe pancreatitis
  • Erik J Simchuk, L.William Traverso, Yuji Nukui, Richard A Kozarek
| Artículo siguiente Artículo siguiente
  • The microbiology of necrotizing soft tissue infections
  • David Elliott, Joseph A Kufera, Roy A.M Myers

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.